← FDA Drug Approvals (Drugs@FDA)

ERYTHROMYCIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2023-08-24

Drug application

FDA Application #

ANDA215661

Application type

Abbreviated New Drug Application (Generic)

Brand name

ERYTHROMYCIN

Generic name

ERYTHROMYCIN

Active ingredients

ERYTHROMYCIN

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

ALEMBIC

Manufacturer

Alembic Pharmaceuticals Inc.

First approval

2023-08-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown